1200
T. Xiao et al. / Journal of Organometallic Chemistry 693 (2008) 1195–1202
to the suspension at 0 °C. The resulting mixture was slowly
warmed to room temperature and stirred over night. The
reaction mixture was then filtered and concentrated by
evaporation. Pure product (1.29 g, 40.3%) was obtained
by column chromatography over silica (hexane/ethyl ace-
tate, 10:1) as yellow oil. Anal. Calc. for C28H40OSi2
(448.79): C, 74.94; H, 8.98. Found: C, 74.89; H, 8.95%.
1H NMR (CDCl3, 300 MHz; 298 K): d 6.90–7.36 (m, 8H,
PhH), 6.33–6.50 (m, 3H, CpH), 5.49–5.52 (s, 1H, PhCH),
2.73 mmol) in hexane (30 ml) at À78 °C. The reaction
mixture was allowed to warm to room temperature
and stirred overnight. The precipitate was filtered off,
and the solvent was removed to leave brown oil.
Recrystallization from CH2Cl2/hexane (1:2) gave pure
5 as yellow crystals (0.55 g, 48.4%). Anal. Calc. for
C22H21Cl2OTi (420.17): C, 62.89; H, 5.04. Found: C,
62.78; H, 5.09%. 1H NMR (CDCl3, 300 MHz; 298 K):
d 6.86–7.34 (m, 8H, PhH), 6.06–6.07 (m, 2H, CpH),
5.91–5.92 (m, 2H, CpH), 5.44 (s, 1H, PhCH), 1.48 (s,
9H, tBu). 13C NMR (CDCl3, 75.4 MHz; 298 K): d
160.5, 149.2, 140.4, 137.4, 130.5, 129.9, 129.5, 128.5,
128.5, 126.0, 123.9, 121.5, 120.9, 120.4, 116.8, 39.7,
31.8, 24.9 ppm.
t
3.29–3.32 (1H, m, CpH), 1.40 (s, 9H, Bu), 0.13 (s, 9H,
OSiMe3), 0.02–0.06 (s, 9H, CpSiMe3).
3.3. Preparation of 2-Me3SiC5H4CHPh-4-MeC6H3OSiMe3
(2)
Compound 2 was synthesized using a procedure identi-
cal to that for 1 with 2-bromo-4-metylphenol (1.78 g,
9.53 mmol) as starting material. Pure product (1.65 g,
33.5%) was obtained as yellow oil. Anal. Calc. for
C25H34OSi2 (406.71): C, 73.83; H, 8.43. Found: C, 73.79;
3.7. Preparation of [g5:g1-2-C5H4CHPh-4-MeC6H3O]-
TiCl2 (6)
Complex 6 was synthesized in the same progress as 5
with 2 (1.07 g, 2.63 mmol) as starting material. Pure prod-
uct was obtained as yellow crystals (0.31 g, 31.3%). Anal.
Calc. for C19H15Cl2OTi (378.09): C, 60.36; H, 4.00. Found:
C, 60.25; H, 4.03%. 1H NMR (CDCl3, 300 MHz; 298 K): d
6.80–7.35 (m, 8H, PhH), 6.02–6.03 (m, 2H, CpH), 5.87–
5.88 (m, 2H, CpH), 5.38 (s, 1H, PhCH), 2.26 (s, 9H,
Me). 13C NMR (CDCl3, 75.4 MHz; 298 K): d 160.3,
148.1, 139.6, 136.3, 134.9, 131.6, 130.7, 129.1, 128.7,
127.8, 123.1, 120.8, 120.1, 119.5, 114.3, 46.9 ppm.
1
H, 8.46%. H NMR (CDCl3, 300 MHz; 298 K): d 6.92–
7.30 (m, 8H, PhH), 6.36–6.47 (m, 3H, CpH), 5.48–5.55
(s, 1H, PhCH), 3.26–3.31 (1H, m, CpH), 2.26 (s, 9H,
PhMe), 0.15 (s, 9H, OSiMe3), 0.01–0.07 (s, 9H, CpSiMe3).
3.4. Preparation of 2-Me3SiC5H4CHPh-4-tBuC6H3OSiMe3
(3)
Compound 3 was synthesized using a procedure identi-
cal to that for 1 with 2-bromo-4-tert-butylphenol (2.24 g,
9.76 mmol) as starting material. Pure product (2.14 g,
39.3%) was obtained as yellow oil. Anal. Calc. for
C28H40OSi2 (448.79): C, 74.94; H, 8.98. Found: C, 74.89;
3.8. Preparation of [g5:g1-2-C5H4CHPh-4-tBuC6H3O]
TiCl2 (7)
Complex 7 was synthesized in the same progress as 5
with 3 (1.49 g, 3.32 mmol) as starting material. Pure prod-
uct was obtained as yellow crystals (0.57 g, 40.6%). Anal.
Calc. for C22H21Cl2OTi (420.17): C, 62.89; H, 5.04. Found:
C, 62.78; H, 5.01%. 1H NMR (CDCl3, 300 MHz; 298 K): d
6.82–7.36 (m, 8H, PhH), 6.04–6.05 (m, 2H, CpH), 5.87–
5.88 (m, 2H, CpH), 5.41 (s, 1H, PhCH), 1.23 (s, 9H,
tBu). 13C NMR (CDCl3, 75.4 MHz; 298 K): d 160.7,
148.2, 139.7, 136.6, 129.7, 129.0, 128.7, 127.6, 127.7,
125.1, 123.0, 120.8, 120.1, 119.6, 113.9, 47.2, 34.5,
31.3 ppm.
1
H, 8.94%. H NMR (CDCl3, 300 MHz; 298 K): d 6.91–
7.40 (m, 8H, PhH), 6.38–6.54 (m, 3H, CpH), 5.54–5.56
(s, 1H, PhCH), 3.24–3.30 (1H, m, CpH), 1.27 (s, 9H,
tBu), 0.15 (s, 9H, OSiMe3), 0.01–0.05 (s, 9H, CpSiMe3).
3.5. Preparation of 2-Me3SiC5H4CHPh-4-tBu-
6-tBuC6H2OSiMe3 (4)
Compound 4 was synthesized using a procedure identi-
cal to that for 1 with 2-bromo-4, 6-di-tert-butylphenol
(2.53 g, 8.86 mmol) as starting material. Pure product
(2.25 g, 48.0%) was obtained as yellow oil. Anal. Calc.
for C32H48OSi2 (504.89): C, 76.12, H, 9.58. Found: C,
3.9. [g5:g1-2-C5H4CHPh-4-tBu-6-tBuC6H2O]TiCl2 (8)
1
76.22, H, 9.61%. H NMR (CDCl3, 300 MHz; 298 K): d
Complex 8 was synthesized in the same progress as 5
with 4 (1.31 g, 2.59 mmol) as starting material. Pure prod-
uct was obtained as yellow crystals (0.69 g, 55.7%). Anal.
Calc. for C26H29Cl2OTi (420.17): C, 65.57; H, 6.14. Found:
C, 65.51; H, 6.16%. 1H NMR (CDCl3, 300 MHz; 298 K): d
6.86–7.36 (m, 7H, PhH), 6.05–6.06 (m, 2H, CpH), 5.84–
5.85 (m, 2H, CpH), 5.44 (s, 1H, PhCH), 1.50 (s, 9H,
o-tBu), 1.24 (s, 9H, p-tBu). 13C NMR (CDCl3, 75.4 MHz;
298 K): d 159.9, 147.3, 140.2, 135.0, 134.5, 130.8, 129.0,
128.6, 127.5, 126.3, 123.1, 122.9, 120.6, 119.7, 119.3, 47.7,
35.2, 34.6, 31.3, 30.2 ppm.
6.98–7.34 (m, 7H, Ph), d 6.32–6.45 (m, 3H, CpH), d
5.43–5.48 (s, 1H, Ph–CH), d 2.92–3.01 (1H, m, CpH), d
1.30 (s, 9H, o-tBu), d 1.23 (s, 9H, p-tBu), d 0.27 (s, 9H,
O–Si–Me3), d 0.10–0.11 (s, 9H, Cp–Si–Me3).
3.6. Preparation of [g5:g1-2-C5H4CHPh-6-tBuC6H3O]-
TiCl2 (5)
A solution of 1 (1.21 g, 2.70 mmol) in hexane (20 ml)
was added dropwise to a solution of TiCl4 (0.3 ml,